headache

An anti-obesity pill that went on sale in Britain this year has been shown to help people lose weight in the first extensive survey of scientific trials of the drug. The drug, rimonabant, went on sale in June and reduces the craving for food by targeting the same part of the brain that gives marijuana users the munchies.
A review of four controlled trials of the drug found it helped people shed a small amount of weight, less than 4.9kg (11lb) in one year, when they were given a high dosage course of 20mg pills. The review, led by Cintia Curioni at the State University of Rio de Janeiro, reported that only patients on the 20mg pills lost weight significantly. But the high dose pills also brought on side effects, including nausea, dizziness, headaches, joint pain and diarrhoea. If you want diagnose of symtoms then visit here .
The drug, selling at £55.20 a patient a month, could cause a financial headache for the NHS if it is recommended by the National Institute for Health and Clinical Excellence.

Desperately seeking sleep, relief
For most of his adult life, Keith Morenos struggle with health problems escalated with inconsistent sleep habits.
His erratic sleep patterns began in the mid- to late-1980s when he did navigation and communications work on B-52 and B-1 bombers through the U.S. Air Force.
And his schedule remains challenging to this day as a full-time senior network engineer at Wells Fargo which requires him to work 12-hour nights in a given week and sharing full-time parenting duties with wife Tawny from their Harris area home.
When you wake up with a headache thats crippling ... a couple of minutes (at my job) could cost a million dollar loss, said Moreno of whats at stake in a high-stress environment.
In light of his regular migraine headache and disruptive sleep habits, Moreno also suspected a disorder due to his family history with sleep apnea. If you want this headache treatment then click here

For the last 12 years -- which, not coincidentally, is the amount of time that I've had a child enrolled in public school -- I've subjected myself to all kinds of headaches.
There's the homework headache. The chaperoning-the-field-trip headache. The minimum days headache. And so forth.
But none of these compares to the headache I get from school fundraisers.
I know, I know, they are a fact of life where education is concerned. If we want our kids to have sports, band, dance, drama, art or science camp, or in other words we want to give them headache treatment then funds must be raised. Not to mention any extracurricular activities our kids might have, such as soccer, baseball, Scouts, karate, gymnastics and the like. They need money, too. It's the never-ending story.
I currently have three fundraisers to deal with.

Computer testing helps identify concussion
NEW YORK (Reuters Health) - A ...

Computer-based test of mental and neurological functioning can help determine whether young athletes have suffered a concussion from a sports-related injury, a new study shows.
Coaches and trainers generally rely on an athlete's own description of symptoms such as dizziness, headache and visual disturbances to determine if he or she has had a concussion, Dr. Mark R. Lovell of the University of Pittsburgh Medical Center, Philadelphia, and colleagues note in the American Journal of Sports Medicine.
However, they add, athletes may often minimize or deny their own symptoms in order to stay in the game or on the team.
The Immediate Postconcussion Assessment and Cognitive Testing (ImPACT) system is a series of tests intended to identify the decline in memory that occurs after concussion and can last for as long as a week, and may offer a more objective way to diagnose concussion in young athletes, Lovell and his team explain.

Researchers at Rush University Medical Center are testing a new treatment for migraine headaches: occipital nerve stimulation, a surgical procedure in which an implanted neurostimulator delivers electrical impulses to nerves under the skin at the base of the head at the back of the neck.

This therapy may help migraine sufferers who do not respond to other available therapies, or who cannot tolerate the side effects of existing medications.

"The purpose of the randomized, double-blinded study is to evaluate the safety and efficacy of occipital nerve stimulation as a treatment for refractory migraine headache," says Dr. Sandeep Amin, Rush study investigator and anesthesiologist who surgically implants the device in the two-visit operation.

Rush is recruiting patients through the Diamond Headache Clinic and is the only site in Illinois in the trial.